prader willi glp 1 Novel therapeutics in rare genetic obesities: A narrative review Frontiers | Case report: Long-term
Description
J Endocrinol 238:R109R119 Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action
In addition to glycemic control, GLP-1 receptor agonists have beneficial other effects
PVH: Para-ventricular hypothalamus
It also aids glucose metabolism and insulin sensitivity, supporting balanced blood sugar and metabolic function
